Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation
Indexado
WoS WOS:000453724600002
Scopus SCOPUS_ID:85055051612
DOI 10.1038/S41379-018-0152-1
Año 2019
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Rosai-Dorfman disease is a rare histiocytic disorder shown to have gene mutations that activate the MAPK/ERK pathway in at least one-third of cases. Most patients with Rosai-Dorfman disease present with bulky lymphadenopathy or extranodal disease, but rarely Rosai-Dorfman disease is detected concomitantly with lymphoma in the same biopsy specimen. The underlying molecular mechanisms of focal Rosai-Dorfman disease occurring in the setting of lymphoma have not been investigated. We report 12 cases of Rosai-Dorfman disease and lymphoma involving the same anatomic site. There were five men and seven women (age, 23 to 77 years) who underwent lymph node (n = 11) or skin (n = 1) biopsy; the lymphomas included nodular lymphocyte predominant Hodgkin lymphoma (n = 6), classical Hodgkin lymphoma (n = 4), small lymphocytic lymphoma (n = 1) and extranodal marginal zone lymphoma (n = 1). The foci of Rosai-Dorfman disease in all cases had S100 protein-positive histiocytes undergoing emperipolesis. No patients had Rosai-Dorfman disease at other anatomic sites at initial diagnosis and at last follow-up (median, 40 months). We performed immunohistochemical analysis to assess activity of the MAPK/ERK pathway in the Rosai-Dorfman disease foci. We also micro-dissected disease foci and analyzed 146 genes using next-generation sequencing in four cases with adequate DNA; the panel included genes previously reported to be mutated in Rosai-Dorfman disease. All cases were negative for gene mutations. Nevertheless, all cases were positive for cyclin D1 and most cases showed p-ERK expression indicating that the MAPK/ERK pathway is active in the histiocytes of focal Rosai-Dorfman disease. We conclude that focal Rosai-Dorfman disease coexisting with lymphoma is a clinically benign and localized histiocytic proliferation. These data also indicate that the MAPK/ERK pathway is active in focal Rosai-Dorfman disease although we did not identify activating mutations. These findings suggest that the pathogenesis of focal Rosai-Dorfman disease is different from that of usual cases of Rosai-Dorfman disease.

Revista



Revista ISSN
Modern Pathology 0893-3952

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Pathology
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Garces, Sofia Mujer Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
2 Yin, C. Cameron - Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
3 Patel, Keyur P. - Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
4 Khoury, Joseph D. Hombre Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
5 MANNING, JOHN T., JR. Hombre Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
6 Li, Shaoying - Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
7 Xu, Jie - Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
8 Pina-Oviedo, Sergio Hombre Univ Arkansas Med Sci - Estados Unidos
University of Arkansas for Medical Sciences - Estados Unidos
UAMS College of Medicine - Estados Unidos
9 Johnson, Malisha R. - Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
10 GONZALEZ-PROVIDELL, SERGIO Hombre Pontificia Universidad Católica de Chile - Chile
Facultad de Medicina - Chile
11 Molgo, Montserrat Mujer Pontificia Universidad Católica de Chile - Chile
Facultad de Medicina - Chile
12 Ruiz-Cordero, Roberto Hombre Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos
13 Medeiros, L. Jeffrey - Univ Texas MD Anderson Canc Ctr - Estados Unidos
University of Texas MD Anderson Cancer Center - Estados Unidos
The University of Texas MD Anderson Cancer Center - Estados Unidos

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
Sin Información

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
Sin Información

Muestra la fuente de financiamiento declarada en la publicación.